Katherine Newton is a chronic disease epidemiologist who is passionate about finding ways to help women stay healthy during midlife. Known for her research on menopause, Dr. Newton is a national leader in the search for non-hormonal treatments for menopausal symptoms.
After a 20-year career as a cardiovascular nurse specialist, Dr. Newton pursued her PhD in epidemiology and shifted her focus to epidemiologic research, joining Group Health Research Institute (GHRI) as a postdoctoral fellow in 1995. Dr. Newton focuses on health concerns for women reaching midlife and on menopause in particular. She has two primary research goals. The first is to help women transition through menopause in the healthiest way possible, and she is especially interested in investigating ways to relieve menopause symptoms without using hormone replacement therapy. Her second goal is to ensure that people with diabetes, or at high risk for diabetes, have access to the information and support they need to stay healthy.
Dr. Newton’s 2006 randomized trial of alternative therapies for menopause received widespread interest, leading to several invited talks around the world. Study analyses continue to yield compelling findings, including a 2007 publication linking low libido in menopause to trouble sleeping. She is currently participating in a multisite network of investigators, MsFLASH Finding Lasting Answers for Symptoms and Health. This group has conducted 5 randomized trials testing the efficacy of yoga, exercise, omega-3 fatty acids, escitalopram and low dose estrogen for menopause symptoms. Dr. Newton’s other areas of interest include studying the intersection of women’s health and chronic disease, especially diabetes and cardiovascular disease.
Dr. Newton is a member of several professional organizations, including the North American Menopause Society, the American Diabetes Association, and the American Heart Association. She sits on the latter’s councils on cardiovascular epidemiology and cardiovascular nursing. Dr. Newton has held two faculty appointments at the University of Washington since 1999, as affiliate associate professor in epidemiology, biobehavioral nursing, and health systems.
Menopause; alternative therapies for menopause; hormone replacement therapy; urinary incontinence; selective estrogen receptor modulators
Diabetes care and prevention; management
Cardiovascular health in women; effect of hormone replacement therapy on cardiovascular health
Thacker EL, Jensen PN, Psaty BM, McKnight B, Longstreth WT, Dublin S, Sitlani CM, Newton KM, Smith NL, Siscovick DS, Heckbert SR.Use of statins and antihypertensive medications in relation to risk of longstanding persistent atrial fibrillation.
Ann Pharmacother. 2015 Jan 27. [Epub ahead of print].
Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O'Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Lafata JE, Butler MG, Kirchner HL, Thomas A, Steiner JF.Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project.
Am J Epidemiol. 2014 Dec 16. pii: kwu255 [Epub ahead of print]. PubMed
Malinowski JR, Denny JC, Bielinski SJ, Basford MA, Bradford Y, Peissig PL, Carrell D, Crosslin DR, Pathak J, Rasmussen L, Pacheco J, Kho A, Newton KM, Li R, Kullo IJ, Chute CG, Chisholm RL, Jarvik GP, Larson EB, McCarty CA, Masys DR, Roden DM, Andrade M, Ritchie MD, Crawford DC.Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.
PLoS One. 2014;9(12):e111301. doi: 10.1371/journal.pone.0111301. eCollection 2014 [Epub 2014, Dec 1].
Caan B, LaCroix AZ, Joffe H, Guthrie KA, Larson JC, Carpenter JS, Cohen LS, Freeman EW, Manson JE, Newton K, Reed S, Rexrode K, Shifren J, Sternfeld B, Ensrud K.Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
Menopause. 2014 Nov 17 [Epub ahead of print]. PubMed
The New York Times, October 4, 2013